NBIX · Categories · Form 4
NBIX - SEC Form 4 insider transactions
Neurocrine Biosciences Inc. (NBIX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for NBIX
- Chief Scientific Officer Onyia Jude was granted 3,587 shares and covered exercise/tax liability with 1,936 shares, increasing direct ownership by 8% to 22,647 units (SEC Form 4) to satisfy withholding tax4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Legal Officer Lippoldt Darin was granted 4,483 shares and covered exercise/tax liability with 2,419 shares, increasing direct ownership by 4% to 56,793 units (SEC Form 4) (withholding obligation)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Medical Officer Keswani Sanjay Chandru was granted 3,914 shares and covered exercise/tax liability with 2,112 shares, increasing direct ownership by 122% to 3,281 units (SEC Form 4) to satisfy tax liability4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Gorman Kevin Charles was granted 14,343 shares and covered exercise/tax liability with 7,839 shares, increasing direct ownership by 1% to 517,797 units (SEC Form 4) to cover taxes4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Executive Officer Gano Kyle was granted 8,117 shares and covered exercise/tax liability with 4,380 shares, increasing direct ownership by 2% to 154,728 units (SEC Form 4) (tax withholding)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Regulatory Officer Delaet Ingrid was granted 4,483 shares and covered exercise/tax liability with 2,419 shares, increasing direct ownership by 13% to 18,289 units (SEC Form 4) (withholding obligation)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Human Resources Officer Cooke Julie was granted 3,587 shares and covered exercise/tax liability with 1,936 shares, increasing direct ownership by 7% to 24,025 units (SEC Form 4) to satisfy withholding obligation4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Corp. Affairs Officer Boyer David W. covered exercise/tax liability with 1,936 shares, sold $130,051 worth of shares (826 units at $157.45) as part of a pre-agreed trading plan and was granted 3,587 shares, increasing direct ownership by 10% to 8,722 units (SEC Form 4) (for withholding tax)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Commercial Officer Benevich Eric was granted 6,275 shares and covered exercise/tax liability with 3,386 shares, increasing direct ownership by 4% to 67,297 units (SEC Form 4) (tax liability)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Financial Officer Abernethy Matt was granted 5,020 shares, covered exercise/tax liability with 2,709 shares and sold $363,285 worth of shares (2,311 units at $157.20) as part of a pre-agreed trading plan (SEC Form 4) to cover withholding tax4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Commercial Officer Benevich Eric sold $333,030 worth of shares (2,154 units at $154.61) as part of a pre-agreed trading plan and exercised 3,194 shares at a strike of $43.24, increasing direct ownership by 2% to 64,408 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Sherwin Stephen A gifted 1,000 shares, decreasing direct ownership by 6% to 14,860 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Scientific Officer Onyia Jude gifted 2,409 shares, decreasing direct ownership by 10% to 20,996 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Norwalk Leslie V sold $227,508 worth of shares (1,250 units at $182.01) as part of a pre-agreed trading plan and exercised 842 shares at a strike of $139.43, decreasing direct ownership by 14% to 2,430 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Regulatory Officer Delaet Ingrid exercised 4,367 shares at a strike of $106.02 and sold $790,514 worth of shares (4,367 units at $181.02) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Legal Officer Lippoldt Darin exercised 10,000 shares at a strike of $81.49 and sold $1,796,014 worth of shares (10,000 units at $179.60) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Regulatory Officer Delaet Ingrid exercised 14,571 shares at a strike of $103.52 and sold $2,603,112 worth of shares (14,571 units at $178.65) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Legal Officer Lippoldt Darin exercised 10,000 shares at a strike of $81.49 and sold $1,701,492 worth of shares (10,000 units at $170.15) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Sherwin Stephen A exercised 25,000 shares at a strike of $64.10 and sold $4,132,969 worth of shares (25,000 units at $165.32) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Scientific Officer Onyia Jude gifted 2,441 shares, decreasing direct ownership by 9% to 23,405 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Norwalk Leslie V sold $210,072 worth of shares (1,250 units at $168.06) as part of a pre-agreed trading plan, decreasing direct ownership by 31% to 2,838 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Human Resources Officer Cooke Julie exercised 24,965 shares at a strike of $81.49 and sold $5,770,235 worth of shares (36,937 units at $156.22) as part of a pre-agreed trading plan, decreasing direct ownership by 35% to 22,374 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Medical Officer Keswani Sanjay Chandru converted options into 3,212 shares and covered exercise/tax liability with 1,733 shares (SEC Form 4) to satisfy tax liability4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Scientific Officer Onyia Jude exercised 11,000 shares at a strike of $84.74 and sold $1,762,710 worth of shares (11,000 units at $160.25) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Regulatory Officer Delaet Ingrid exercised 2,261 shares at a strike of $79.02 and sold $354,321 worth of shares (2,261 units at $156.71) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Scientific Officer Onyia Jude exercised 11,000 shares at a strike of $84.74 and sold $1,710,865 worth of shares (11,000 units at $155.53) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Gorman Kevin Charles4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Pops Richard F4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Lyons Gary A4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Mercier Johanna4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Poon Christine A4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Sharp Shalini4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Sherwin Stephen A4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Morrow George J4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Rastetter William H4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- SEC Form 4 filed by Director Norwalk Leslie V4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Corp. Affairs Officer Boyer David W. sold $609,023 worth of shares (3,888 units at $156.64) as part of a pre-agreed trading plan, decreasing direct ownership by 33% to 7,799 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Sherwin Stephen A converted options into 3,318 shares, increasing direct ownership by 26% to 15,860 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Sharp Shalini converted options into 1,659 shares, increasing direct ownership by 68% to 4,088 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Rastetter William H converted options into 3,318 shares, increasing direct ownership by 8% to 43,678 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Pops Richard F converted options into 3,318 shares, increasing direct ownership by 10% to 37,798 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Poon Christine A converted options into 3,318 shares, increasing direct ownership by 231% to 4,753 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Norwalk Leslie V converted options into 1,659 shares, increasing direct ownership by 68% to 4,088 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Morrow George J converted options into 3,318 shares, increasing direct ownership by 47% to 10,386 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Mercier Johanna converted options into 3,318 shares, increasing direct ownership by 94% to 6,853 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Lyons Gary A converted options into 1,659 shares, increasing direct ownership by 1% to 122,141 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Gorman Kevin Charles exercised 205,088 shares at a strike of $43.24 and sold $37,824,872 worth of shares (245,088 units at $154.33) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 511,293 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Pops Richard F exercised 15,000 shares at a strike of $47.89 and sold $2,364,760 worth of shares (15,000 units at $157.65) as part of a pre-agreed trading plan (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Norwalk Leslie V sold $590,601 worth of shares (3,810 units at $155.01) as part of a pre-agreed trading plan, decreasing direct ownership by 61% to 2,429 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Financial Officer Abernethy Matt gifted 2,249 shares, decreasing direct ownership by 5% to 42,808 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Scientific Officer Onyia Jude gifted 3,110 shares, decreasing direct ownership by 11% to 25,670 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Financial Officer Abernethy Matt converted options into 6,940 shares, covered exercise/tax liability with 9,124 shares and was granted 9,968 shares, increasing direct ownership by 21% to 44,881 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Corp. Affairs Officer Boyer David W. covered exercise/tax liability with 8,052 shares, was granted 9,968 shares and converted options into 4,952 shares, increasing direct ownership by 146% to 11,581 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Executive Officer Gano Kyle converted options into 9,714 shares, covered exercise/tax liability with 10,621 shares and was granted 9,968 shares, increasing direct ownership by 6% to 150,815 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Scientific Officer Onyia Jude was granted 19,935 shares, converted options into 7,967 shares and covered exercise/tax liability with 15,099 shares, increasing direct ownership by 80% to 28,780 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Commercial Officer Benevich Eric converted options into 6,049 shares, covered exercise/tax liability with 12,227 shares and was granted 16,613 shares, increasing direct ownership by 20% to 63,190 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Human Resources Officer Cooke Julie was granted 9,968 shares, converted options into 4,298 shares and covered exercise/tax liability with 7,698 shares, increasing direct ownership by 24% to 34,170 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Legal Officer Lippoldt Darin converted options into 5,892 shares, covered exercise/tax liability with 8,558 shares, was granted 9,968 shares and gifted 365 shares, increasing direct ownership by 15% to 54,729 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Chief Regulatory Officer Delaet Ingrid covered exercise/tax liability with 13,126 shares, was granted 19,935 shares and converted options into 4,360 shares, increasing direct ownership by 221% to 16,225 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)
- Director Gorman Kevin Charles converted options into 10,981 shares, covered exercise/tax liability with 40,305 shares and was granted 63,724 shares, increasing direct ownership by 7% to 551,293 units (SEC Form 4)4 - NEUROCRINE BIOSCIENCES INC (0000914475) (Issuer)